The ability of p-coumaric acid to decrease oxidative damage, focal ischemia, and neurological deficit scores in the brain of rats characterized by cerebral ischemia is attributable to its antioxidant (decreased MDA) and anti-apoptotic (decreased caspase-3) activity. Here, CASP3 is linked to brain ischemia.